FATE - Fate Therapeutics Inc. (FATE) CEO Scott Wolchko on Q3 2021 Results - Earnings Call Transcript

Fate Therapeutics, Inc. (FATE) Q3 2021 Earnings Conference Call November 4, 2021, 05:00 PM ET Company Participants Scott Wolchko - President and CEO Ed Dulac - CFO Wayne Chu - SVP, Clinical development Conference Call Participants Michael Yee - Jefferies Mike Ulz - Morgan Stanley Alethia Young - Cantor Peter Lawson - Barclays Daina Graybosch - SVB Srikripa Devarakonda - Truist Securities Matt Biegler - Oppenheimer Mara Goldstein - Mizuho Nick Abbott - Wells Fargo Ted Tenthoff - Piper Sandler Rob Burns - H.C. Wainwright Presentation Operator Welcome to the Fate Therapeutics Third Quarter 2021 Financial Results Conference Call. At this time all participants are in a listen-only mode. This call is being webcast live on the Investors section of Fate's website at fatetherapeutics.com. As a reminder, today's call is being recorded. I would now like to introduce Scott Wolchko, President and CEO of Fate Therapeutics. Scott Wolchko Thank you.

For further details see:

Fate Therapeutics, Inc. (FATE) CEO Scott Wolchko on Q3 2021 Results - Earnings Call Transcript